Literature DB >> 7848097

Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome after failure of surgical shunting.

A Rogopoulos1, A Gavelli, H Sakai, M McNamara, C Huguet.   

Abstract

A case of acute Budd-Chiari syndrome in a 26-year-old woman is reported. After a mesocaval shunt, the patient remained asymptomatic for 21 months, but ascites and hepatomegaly reappeared due to inferior vena cava stenosis subsequently treated by balloon dilation. Recurrence of stenosis indicated the need for a cavoatrial shunt with an expanded polytetrafluoroethylene prosthesis, which was followed by a complete recovery during the next 29 months. Radiological follow-up with magnetic resonance imaging demonstrated progressive hepatomegaly, thrombosis of the cavoatrial shunt, and stenosis of the mesocaval shunt. A transjugular intrahepatic portosystemic shunt was carried out, despite the absence of any patent residual hepatic vein at the usual level, by perforating the inferior vena cava and liver up to the right portal vein. An expandable 12-mm stent was successful in decreasing liver congestion. Dilation of the transjugular intrahepatic portosystemic shunt was done 15 months later, and the patient remains asymptomatic after a follow-up of 18 months.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7848097     DOI: 10.1001/archsurg.1995.01430020117024

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Beware of TIPPSters.

Authors:  A Gimson
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

2.  Budd-Chiari syndrome: current management options.

Authors:  D P Slakey; A S Klein; A C Venbrux; J L Cameron
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Transcaval TIPS in patients with failed revision of occluded previous TIPS.

Authors:  C K Seong; Y J Kim; T B Shin; H Y Park; T H Kim; D S Kang
Journal:  Korean J Radiol       Date:  2001 Oct-Dec       Impact factor: 3.500

4.  Transcaval transjugular intrahepatic portosystemic shunt: preliminary clinical results.

Authors:  Kwang-Hun Lee; Do-Yun Lee; Jong-Yoon Won; Sang Joon Park; Jae Kyu Kim; Woong Yoon
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

5.  Selective management of hepatic venous outflow obstruction.

Authors:  G G Tsiotos; D M Nagorney
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

6.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

7.  Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.

Authors:  Gauri Mukhiya; Xueliang Zhou; Xinwei Han; Dechao Jiao; Gaurab Pokhrel; Yahua Li; Sita Pokhrel
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.